icon-folder.gif   Conference Reports for NATAP  
 
 

AASLD

The Liver Meeting
Washington DC
October 2017
Back grey_arrow_rt.gif
 
 
 
Regression of liver stiffness (LS) after direct acting anti-viral (DAA) therapy for hepatitis C in the country of Georgia
 
 
    Reported by Jules Levin
AASLD Liver Meeting Oct 20-24 2017, Washington DC 
 
Dolmazashvili E.1,2,3, Abutidze A.1,2, Karchava M.1,2, Sharvadze L.1,2,3, Chkhartishvili N2, Tsertsvadze T.1,2,3
 
Hepatology Clinic "HEPA"1Infectious Diseases, AIDS & Clinical Immunology Research Center2 Iv. Javakhishvili Tbilisi State University3

1106171

1106172

1106173

References
 
1.EASL Recommendations on Treatment of Hepatitis C 2016 EASL. J Hepatol 2016 2.Salmon D, Dabis F, Wittkop L, Esterle L, Sogni P, Trimoulet P, Regression of liver stiffness after sustained hepatitis C virus (HCV) virological responses among HIV/HCV-coinfected patients.ANRS CO13HEPAVIH Cohort. AIDS2015,29:1821-1830. 3. Hezode C, Castera L, Roudot-Thoraval F, Bouvier-Alias M, Rosa I, Roulot D, et al. Liver stiffness diminishes with antiviral response in chronic hepatitis C. Aliment Pharmacol Ther 2011,34:656-663.